ACHILLION PHARMACEUTICALS IN's ticker is and the CUSIP is 00448Q901. A total of 4 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $286,000 | -35.7% | 992 | 0.0% | 0.03% | -10.3% |
| Q3 2017 | $445,000 | -22.5% | 992 | -20.6% | 0.03% | -23.7% |
| Q2 2017 | $574,000 | -78.6% | 1,250 | -80.4% | 0.04% | -73.8% |
| Q1 2017 | $2,679,000 | -35.7% | 6,363 | -36.9% | 0.14% | -40.1% |
| Q4 2016 | $4,166,000 | -43.1% | 10,087 | +11.6% | 0.24% | -11.7% |
| Q3 2016 | $7,322,000 | +145.3% | 9,039 | +136.2% | 0.27% | +75.6% |
| Q2 2016 | $2,985,000 | +68.3% | 3,827 | +66.5% | 0.16% | +75.3% |
| Q1 2016 | $1,774,000 | -72.0% | 2,298 | -60.9% | 0.09% | -74.5% |
| Q4 2015 | $6,342,000 | +32.7% | 5,878 | -15.0% | 0.35% | +77.2% |
| Q3 2015 | $4,779,000 | -22.0% | 6,916 | 0.0% | 0.20% | -12.1% |
| Q2 2015 | $6,128,000 | +14.3% | 6,916 | +27.2% | 0.22% | +0.4% |
| Q1 2015 | $5,363,000 | +61.0% | 5,439 | +100.0% | 0.22% | +112.4% |
| Q4 2014 | $3,331,000 | -76.5% | 2,719 | -80.9% | 0.10% | -80.7% |
| Q3 2014 | $14,187,000 | +17.2% | 14,215 | -11.1% | 0.54% | +5.0% |
| Q2 2014 | $12,102,000 | +150.4% | 15,987 | +8.8% | 0.52% | +91.5% |
| Q1 2014 | $4,834,000 | -35.5% | 14,693 | -34.9% | 0.27% | -43.3% |
| Q4 2013 | $7,496,000 | +2.8% | 22,579 | -6.5% | 0.48% | +0.8% |
| Q3 2013 | $7,290,000 | +19.1% | 24,139 | +222.7% | 0.47% | +16.2% |
| Q2 2013 | $6,119,000 | – | 7,480 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 77,300 | $466,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 286 | $172,000 | 0.00% |